Great insights at the ” ESMO Molecular Analysis for Precision Oncology Congress 2024 ” in London!
October, 25 2024 - < 1 min read
During the session on “Ethical and Regulatory Aspects for Implementing AI in Clinical Trials,” Arsela Prelaj, our I3LUNG partner from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, delivered a talk on “AI for Immuno-Oncology.”
Her presentation highlighted how artificial intelligence is driving advancements in personalized cancer treatments and shaping the future of immunotherapy. A huge step forward for the I3LUNG project and AI-driven solutions in clinical research!
Stay tuned for more information and don’t forget to follow us on our social networks:
LinkedIn | Twitter | Instagram | Facebook
Share on: